D. Adeloye, S. Chua, C. Lee, C. Basquill, A. Papana et al., Rudan I1; Global Health Epidemiology Reference Group (GHERG) ; Global and regional estimates of COPD prevalence: Systematic review and meta-analysis

J. Health, , vol.5, p.20415, 2015.

, World Health Organisation. World Health Organisation (WHO) Website, 2016.

C. Fuhrman and M. C. Delmas, Épidémiologie descriptive de la bronchopneumopathie chronique obstructive (BPCO) en France, Revue des Maladies Respiratoires, vol.27, issue.2, pp.160-168, 2010.

M. Fournier, A. B. Tonnel, B. Housset, G. Huchon, P. Godard et al., Impact économique de la BPCO en France: étude SCOPE, Revue des maladies respiratoires, vol.22, issue.2, pp.247-255, 2005.

I. Lucas-m-a-goossens1 and . Leimer2,

M. H-rutten-van-mölken1, Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial, BMC Pulmonary Medicine, vol.14, p.163, 2014.

C. Chen, M. D. , C. Ou, M. D. , C. Yu et al.,

M. D. , H. Chang, M. D. , T. Hsiue, and M. D. , Comparison of Global Initiative for Chronic ObstructivePulmonary Disease 2013 Classification and Body Mass Index,Airflow Obstruction, Dyspnea, and Exacerbations Index in Predicting Mortality and Exacerbations in Elderly Adults with Chronic Obstructive Pulmonary Disease, Journal of The Amrican Geriatrics Society, vol.63, pp.244-250, 2015.

, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2017.

M. D. Eisner, N. Anthonisen, and D. Coultas, An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.182, issue.5, pp.693-718, 2010.

M. Zysmana, F. Chabota, P. Devillier-b, B. Houssetc, C. Morelot-panzinid et al., Optimisation du traitement médicamenteux des patients atteints de bronchopneumopathie chronique obstructive en état stable

, , 2016.

M. Decramer, A. Rossi, and D. Lawrence, Indacaterol therapy in patients with COPD not receiving other maintenance treatment, Respir Med, vol.106, pp.1706-1714, 2012.

M. Decramer, A. Anzueto, and E. Kerwin, Efficacy and safety ofumeclidinium plus vilanterol versus tiotropium, vilanterol, orumeclidinium monotherapies over 24 weeks in patients withchronic obstructive pulmonary disease: results from two mul-ticentre, blinded, randomised controlled trials, Lancet RespirMed, vol.2, pp.472-86, 2014.

J. A. Wedzicha, M. Decramer, and J. H. Ficker, Analysis of chronicobstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium andtiotropium (SPARK): a randomised, double-blind, parallel-group study, Lancet Respir Med, vol.1, pp.199-209, 2013.

L. Calzetta, P. Rogliani, and M. G. Matera, A systematic reviewwith meta-analysis of dual bronchodilation with LAMA/LABAfor the treatment of stable COPD, Chest, vol.149, pp.1181-96, 2016.

L. J. Nannini, P. Poole, S. J. Milan, and A. Kesterton, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.8, issue.8, p.6826, 2013.

I. A. Yang, M. S. Clarke, E. H. Sim, and K. M. Fong, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.7, issue.7, p.2991, 2012.

S. C. Herath and P. Poole, Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD), Cochrane Database Syst Rev, issue.11, p.9764, 2013.

H. Publique,

, Mis à jour le 10 Mars, 2017.

P. Surpas and S. Stelianides, Qu'est-ce que la réhabilitation respiratoire en 2015? Revue des Maladies Respiratoire, vol.32, pp.893-894, 2015.

B. Mccarthy, D. Casey, D. Devane, K. Murphy, E. Murphy et al., Pulmonary rehabilitation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 2015.

P. B. Murphy, S. Rehal, G. Arbane, S. Bourke, P. M. Calverley et al.,

J. R. Hurst, Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial, Jama, issue.21, pp.2177-2186, 2017.

G. Deslée, H. Mal, H. Dutau, A. Bourdin, J. M. Vergnon et al.,

L. Thiberville, S. Leroy, A. Marceau, S. Laroumagne, J. P. Mallet et al., for the REVOLENS Study Group. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe EmphysemaThe REVOLENS Randomized Clinical Trial, JAMA, vol.315, issue.2, pp.175-184, 2016.

, World Health Organization. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL), Qual Life Res, vol.2, pp.153-162, 1993.

M. Mercier, Qualité de vie : quels outils de mesure ? 27es journées de la SFSPM, 2005.

Y. Lacasse and F. Seriès, Qualité de vie liée à la santé: un guide de lecture, Rev Mal Respir, vol.20, pp.580-588, 2003.

L. B. Apa-mokkink, C. B. Terwee, D. L. Patrick, J. Alonso, P. W. Stratford et al., The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patientreported outcomes, Journal of clinical epidemiology, vol.63, issue.7, pp.737-745, 2010.

F. Tubach and P. Ravaud, Différence minimale cliniquement importante et état symptomatique cliniquement acceptable, deux concepts pour aider à l'interprétation des essais cliniques

P. Jones, Quality of life measurement for patients with diseases of the airways, Thorax, vol.46, issue.9, pp.676-82, 1991.

C. Préfaut and G. Ninot, La réhabilitation du malade respiratoire chronique, Revue des Maladies Respiratoires, vol.26, issue.9, p.1018, 2009.

P. Jones, F. H. Quirk, C. M. Baveystock, and P. Littlejohns, A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire, Am Rev Respir Dis, vol.145, issue.6, pp.1321-1328, 1992.

P. W. Jones, St. George's respiratory questionnaire: MCID. COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.2, pp.75-79, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00989481

G. Ninot, F. Soyez, S. Fiocco, K. Nassih, A. J. Morin et al., The VQ11, a short healthrelated quality of life questionnaire for routine practice in COPD patients

, Rev Mal Respir, vol.27, issue.5, pp.472-81, 2010.

G. Ninot, F. Soyez, and C. Préfaut, A short questionnaire for the assessment of quality of life in patients with chronic obstructive pulmonary disease: psychometric properties of VQ11
URL : https://hal.archives-ouvertes.fr/inserm-00908816

, Health Qual Life Outcomes, vol.11, p.179, 2013.

, Manuel d'utilisation du VQ11. Laboratoire Epsylon, 2010.

, Siebrig Schokker1, Nick HT ten Hacken3, Dirkje S Postma3 and Elizabeth F Juniper4Development, validity and responsiveness of the Clinical COPD Questionnaire, Thys van der Molen*1,5, Brigitte WM Willemse2, vol.1, 2003.

P. , Jones Development and first validation of the COPD assement test, Eur Respir J, 2009.

E. Marchand, Evaluation du CAT chez les patients BPCO en état stable, Revue des Maladies Respiratoires, 2012.
DOI : 10.1016/j.rmr.2011.09.043

G. H. Guyatt, L. B. Berman, M. Townsend, S. O. Pugsley, and L. W. Chambers, , 1987.

, A measure of quality of life for clinical trials in chronic lung disease, Thorax, vol.42, issue.10, pp.773-778

C. L. Tsai, R. V. Hodder, J. H. Page, R. K. Cydulka, B. H. Rowe et al., The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease, Journal of clinical epidemiology, vol.61, issue.5, pp.489-497, 2008.

T. Perez, B. Arnould, and J. Grosbois, Validity, reliability, and responsiveness of a new shortVisual Simplified Respiratory Questionnaire (VSRQ©) for health-related quality of life assessment in chronic obstructive pulmonary disease, International Journal of Chronic Obstructive Pulmonary Disease, vol.4, pp.9-18, 2009.

M. Westwood, J. Bourbeau, P. W. Jones, A. Cerulli, G. Capkun-niggli et al., Relationship between FEV 1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review, Respiratory research, vol.12, issue.1, p.40, 2011.

, Annexe 1: Classification GOLD, 2007.

, Annexe 2: Echelle mMRC

, COPD Assessment Test Annexe, vol.3